tm
Seeing Is Believing
tm
Seeing Is Believing
SKYE is currently covered by 1 analysts with an average price target of $10.95. This is a potential upside of $9.94 (984.16%) from yesterday's end of day stock price of $1.01.
Skye Bioscience, Common Stock's activity chart (see below) currently has 8 price targets and 11 ratings on display. The stock rating distribution of SKYE is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 7.33 days.
Highest price target for SKYE is $15, Lowest price target is $15, average price target is $15.
Most recent stock forecast was given by JONATHAN WOLLEBEN from JMP on 24-Jun-2025. First documented stock forecast 05-Feb-2024.
Currently out of the existing stock ratings of SKYE, 2 are a BUY (100%).
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 10-Sep-2024
$15
$13.99 (1385.15%)
7 months ago
(24-Jun-2025)
0/2 (0%)
$11.38 (314.36%)
Buy
Since 23-May-2024
$14
$12.99 (1286.14%)
$14
1 years 4 months 4 days ago
(20-Sep-2024)
0/6 (0%)
$10.86 (345.86%)
Buy
Since 05-Feb-2024
$12
1 years 4 months 4 days ago
(20-Sep-2024)
1/1 (100%)
$7.57 (170.88%)
22
What is SKYE (Skye Bioscience, Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on SKYE (Skye Bioscience, Common Stock) with a proven track record?
Which analyst has the current lower performing score on SKYE (Skye Bioscience, Common Stock) with a proven track record?
Which analyst has the most public recommendations on SKYE (Skye Bioscience, Common Stock)?
Which analyst is the currently most bullish on SKYE (Skye Bioscience, Common Stock)?
Which analyst is the currently most reserved on SKYE (Skye Bioscience, Common Stock)?
